Sign up to save your podcasts
Or
Share Shanu Modi, MD, Discusses the DESTINY-Breast01 Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Shanu Modi, MD, Discusses the DESTINY-Breast01 Trial
Dr Modi discusses the basis, clinical significance, and findings of the DESTINY-Breast04 trial of DS-8201a therapy for HER2-low breast cancer.
View all episodes
By HMP GlobalDr Modi discusses the basis, clinical significance, and findings of the DESTINY-Breast04 trial of DS-8201a therapy for HER2-low breast cancer.